Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluate the Safety and Efficacy of ALLN-177 in Patients with Enteric Hyperoxaluria
2017-004352-33Phase 3Completed
- Sponsor
- Allena Pharmaceuticals, Inc.
- Start
- Mar 2018
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of reloxaliase in absorptive hyperoxaluria, sponsored by Allena Pharmaceuticals, Inc.. Started Mar 2018; status: completed.
02
Drugs
reloxaliase
03
Conditions
absorptive hyperoxaluria
Beyond the preview
Go deeper on 2017-004352-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004352-33.